Close Menu

In Cell this week, researchers in Italy say that TAZ, a transducer of the Hippo pathway, is responsible for conferring the properties of cancer stem cells onto breast cancer cells. TAZ is required to sustain self-renewal and tumor-initiation capacities in breast cancer stem cells, the authors write. "TAZ protein levels and activity are elevated in prospective CSCs and in poorly differentiated human tumors and have prognostic value," they add.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports on how meeting cancellations and related costs are affecting scientific societies.

In a new ruling, Canada's Supreme Court upheld the country's genetic non-discrimination law, the Canadian Press reports.

COVID-19 vaccine developers aim to avoid a complication that has affected efforts to develop vaccines for other diseases, the Wall Street Journal reports.

In PLOS this week: analysis of insertions throughout Shigella genomes, antigen production in malaria parasites, and more.